FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078267079> ?p ?o ?g. }

• W2078267079 endingPage "1940" @default.
• W2078267079 startingPage "1929" @default.
• W2078267079 abstract "The purpose of this study was to investigate the abortifacient effects of high doses of metergoline when administered to pregnant beagle bitches during the second half of gestation and to define the endocrine effects of this treatment as represented by plasma progesterone and estradiol concentrations. Previously, metergoline had been shown to be incompletely luteolytic and induced abortion in only one of eight pregnant bitches when 0.4–0.5 mg/kg were administered twice daily for 5 days from Days 18 to 20 of diestrus. Nine pregnancies in six beagle bitches were used for the present study. Three bitches were treated in each of two consecutive pregnant cycles. Metergoline was administered at a dose of 0.6 mg/kg per os twice daily, starting on Day 28 after the cytological onset of diestrus. Abortion was induced in eight of the nine treated pregnancies and started after 3–23 days of treatment (mean 12.5 days, S.D. 6.4 days). The abortions were completed within 0.5–8 days (mean 2.2 days, S.D. 2.7 days). There were no side effects associated with metergoline treatment and none of the abortions was associated with complications that required intervention. In the single bitch that did not abort, an ovarian granulosa cell tumor was discovered when the single fetus had to be removed surgically at term. Plasma progesterone concentrations declined after the start of metergoline administration in all pregnancies but levels below 4.8 nmol/l were required for successful abortions. Plasma estradiol concentrations showed a tendency to decline and fluctuate concurrently with the plasma progesterone levels. However, suppression of plasma estradiol concentrations by metergoline was not as complete as the suppression of progesterone and did not seem a prerequisite for abortion. The hormone profiles and treatment period required for abortion tended to be similar for both cycles of the three bitches that were treated during two consecutive pregnancies. This suggests a bitch effect on the factors that determine the efficacy of metergoline to induce abortion. The large variation and length of the treatment period that was required until abortion commenced was probably related to the relatively early start of treatment compared to other studies. The results of this investigation suggest that, similar to other prolactin suppressing ergot derivatives, metergoline causes complete luteolysis and can be used to reliably induce abortion only during the last 3 weeks of gestation." @default.
• W2078267079 created "2016-06-24" @default.
• W2078267079 creator A5007810009 @default.
• W2078267079 creator A5036303847 @default.
• W2078267079 creator A5036782637 @default.
• W2078267079 creator A5069464738 @default.
• W2078267079 creator A5075025175 @default.
• W2078267079 date "2003-05-01" @default.
• W2078267079 modified "2023-09-24" @default.
• W2078267079 title "Abortifacient and endocrine effects of metergoline in beagle bitches during the second half of gestation" @default.
• W2078267079 cites W131450071 @default.
• W2078267079 cites W1473889530 @default.
• W2078267079 cites W1516780959 @default.
• W2078267079 cites W1528861281 @default.
• W2078267079 cites W1719271326 @default.
• W2078267079 cites W191649432 @default.
• W2078267079 cites W1973889576 @default.
• W2078267079 cites W197788719 @default.
• W2078267079 cites W1978227481 @default.
• W2078267079 cites W1978846268 @default.
• W2078267079 cites W1990261272 @default.
• W2078267079 cites W2007791929 @default.
• W2078267079 cites W2011024648 @default.
• W2078267079 cites W2014436911 @default.
• W2078267079 cites W2027052913 @default.
• W2078267079 cites W2027859069 @default.
• W2078267079 cites W2031052681 @default.
• W2078267079 cites W2037363798 @default.
• W2078267079 cites W2041129459 @default.
• W2078267079 cites W2042213039 @default.
• W2078267079 cites W2055367917 @default.
• W2078267079 cites W2067293675 @default.
• W2078267079 cites W2067349870 @default.
• W2078267079 cites W2073244260 @default.
• W2078267079 cites W2077167408 @default.
• W2078267079 cites W2080932557 @default.
• W2078267079 cites W2081710714 @default.
• W2078267079 cites W2088928420 @default.
• W2078267079 cites W2116342156 @default.
• W2078267079 cites W2120126426 @default.
• W2078267079 cites W2172120725 @default.
• W2078267079 cites W2407895255 @default.
• W2078267079 cites W2410642606 @default.
• W2078267079 cites W2416290578 @default.
• W2078267079 cites W2416414832 @default.
• W2078267079 cites W2417408865 @default.
• W2078267079 cites W2433003659 @default.
• W2078267079 cites W2438242275 @default.
• W2078267079 cites W2754519367 @default.
• W2078267079 cites W27766888 @default.
• W2078267079 cites W292529533 @default.
• W2078267079 cites W37254 @default.
• W2078267079 cites W72231907 @default.
• W2078267079 cites W109567507 @default.
• W2078267079 cites W15924340 @default.
• W2078267079 cites W2411444009 @default.
• W2078267079 cites W2487452104 @default.
• W2078267079 cites W607264982 @default.
• W2078267079 doi "https://doi.org/10.1016/s0093-691x(02)01292-x" @default.
• W2078267079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12600730" @default.
• W2078267079 hasPublicationYear "2003" @default.
• W2078267079 type Work @default.
• W2078267079 sameAs 2078267079 @default.
• W2078267079 citedByCount "12" @default.
• W2078267079 countsByYear W20782670792014 @default.
• W2078267079 countsByYear W20782670792016 @default.
• W2078267079 countsByYear W20782670792018 @default.
• W2078267079 crossrefType "journal-article" @default.
• W2078267079 hasAuthorship W2078267079A5007810009 @default.
• W2078267079 hasAuthorship W2078267079A5036303847 @default.
• W2078267079 hasAuthorship W2078267079A5036782637 @default.
• W2078267079 hasAuthorship W2078267079A5069464738 @default.
• W2078267079 hasAuthorship W2078267079A5075025175 @default.
• W2078267079 hasConcept C126322002 @default.
• W2078267079 hasConcept C134018914 @default.
• W2078267079 hasConcept C170493617 @default.
• W2078267079 hasConcept C2775864247 @default.
• W2078267079 hasConcept C2776106523 @default.
• W2078267079 hasConcept C2776120623 @default.
• W2078267079 hasConcept C2776820430 @default.
• W2078267079 hasConcept C2777702977 @default.
• W2078267079 hasConcept C2778642596 @default.
• W2078267079 hasConcept C2779234561 @default.
• W2078267079 hasConcept C46699223 @default.
• W2078267079 hasConcept C46973012 @default.
• W2078267079 hasConcept C53910766 @default.
• W2078267079 hasConcept C54355233 @default.
• W2078267079 hasConcept C71315377 @default.
• W2078267079 hasConcept C71924100 @default.
• W2078267079 hasConcept C86803240 @default.
• W2078267079 hasConceptScore W2078267079C126322002 @default.
• W2078267079 hasConceptScore W2078267079C134018914 @default.
• W2078267079 hasConceptScore W2078267079C170493617 @default.
• W2078267079 hasConceptScore W2078267079C2775864247 @default.
• W2078267079 hasConceptScore W2078267079C2776106523 @default.
• W2078267079 hasConceptScore W2078267079C2776120623 @default.
• W2078267079 hasConceptScore W2078267079C2776820430 @default.
• W2078267079 hasConceptScore W2078267079C2777702977 @default.

• next